Diko : en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

Catégories

Nom

Informations lexicales

Langue:anglais

Informations sémantiques

source:wiki

Liens externes

›

umls:C4067491

Associations d'idées

[F]

›

362

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:patient was not referred to hospice care, reason not given

•

en:patient survey results not available

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:imaging study named according to standardized nomenclature

•

en:shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:elective surgical procedure

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:no documentation of negative or managed positive tb screen

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:prior thyroid disease diagnosis

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient transferred directly from anesthetizing location to pacu

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:statin not prescribed at discharge

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:intent for potential removal at time of placement

•

en:final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:documentation that the patient is not on a statin medication

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of medical reason(s) for not including documentation that follow up imaging is not needed (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:documentation of active injection drug use

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient received follow-up within 7 days from discharge

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:p2y inhibitor not prescribed at discharge

•

en:operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed

•

en:i intend to report the diabetic retinopathy measures group

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:documentation of patient with one or more complications within 90 days

•

en:documentation of patient survival and absence of stroke following cas

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:p2y inhibitor prescribed at discharge

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:patient survey score did not improve from baseline following treatment

•

en:patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:patient not discharged to home by post-operative day #7

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:currently a tobacco non-user

•

en:all necessary data elements not included, reason not given

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:surgical site infection

•

en:preoperative assessment not documented, reason not given

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:mapcp demonstration - state provided services

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:elective delivery or early induction not performed

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

•

en:patient offered assistance with end of life issues during the measurement period

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:statin prescribed at discharge

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:patient required a return to the operating room within 90 days of surgery

•

en:antibiotic regimen prescribed

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:i intend to report the cardiovascular prevention measures group

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:documentation that patient is a current tobacco user

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:antiretroviral therapy prescribed

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patients with 90 day mrs score of 0 to 2

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:history of receiving blood transfusions prior to 1992

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:patients who were born in the years 1945-1965

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:national committee for quality assurance - level 3 medical home

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:i intend to report the general surgery measures group

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:documentation of viral load less than 200 copies/ml

•

en:documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:biologic immune response modifier prescribed

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors

•

en:final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:preoperative assessment documented

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:post-partum screenings, evaluations and education not performed

•

en:history of injection drug use

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:mapcp demonstration - physician incentive pool

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:patient discharge to home no later than post-operative day #7

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:documented reason for not assessing hepatitis b virus (hbv) status (e.g. patient not receiving a first course of anti-tnf therapy, patient declined) within one year prior to first course of anti-tnf therapy

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:documentation of patient stroke following cea

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:aspirin prescribed at discharge

•

en:aspirin not prescribed at discharge

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:post-partum screenings, evaluations and education performed

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:patient survey score improved from baseline following treatment

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:door to puncture time of less than 2 hours

•

en:filter removed within 3 months of placement

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)

•

en:national committee for quality assurance - level 2 medical home

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:patient received one-time screening for hcv infection

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patients with 90 day mrs score greater than 2

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:i intend to report the total knee replacement measures group

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:at least two different high-risk medications not ordered

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:documentation of planned hybrid or staged procedure

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:at least two different high-risk medications ordered

•

en:i intend to report the sinusitis measures group

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:documentation of patient stroke following cas

•

en:beta-blocker therapy prescribed or currently being taken

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient was referred to hospice care

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:foot exam was not performed, reason not given

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:beta-blocker therapy not prescribed, reason not given

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:individual did not have a pdc of 0.8 or greater

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:specimen site other than anatomic cutaneous location

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:one high-risk medication not ordered

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:mapcp demonstration - community health teams

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)

•

en:current cigarette smokers

•

en:no surgical site infection

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:one high-risk medication ordered

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:national committee for quality assurance - level 1 medical home

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.)

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient alive 3 months post procedure

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:patient taking tamsulosin hydrochloride

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:individual had a pdc of 0.8 or greater

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:documentation that patient is a current non-tobacco user

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patients with a normal neurological examination

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:patients with clinical ascvd diagnosis

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:monitored anesthesia care (mac)

•

en:documentation of patient death following cas

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:elective delivery or early induction performed

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:antiretroviral thereapy not prescribed

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:admission to medicare care choice model program (mccm)

•

en:patients prescribed opiates for longer than six weeks

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:i intend to report the multiple chronic conditions measures group

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:documentation of patient death following cea

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

intervention chirurgicale à froid

◀

‹

362

en:specimen site other than anatomic cutaneous location

•

en:patient offered assistance with end of life issues during the measurement period

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:no surgical site infection

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:i intend to report the sinusitis measures group

•

en:surgical site infection

•

en:patient discharge to home no later than post-operative day #7

•

en:patient received one-time screening for hcv infection

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

intervention chirurgicale à froid

•

en:elective surgical procedure

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:p2y inhibitor not prescribed at discharge

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:one high-risk medication not ordered

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:mapcp demonstration - state provided services

•

en:documentation of patient stroke following cas

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:i intend to report the multiple chronic conditions measures group

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:patient taking tamsulosin hydrochloride

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:documentation of patient death following cea

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:elective delivery or early induction performed

•

en:at least two different high-risk medications not ordered

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient was referred to hospice care

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:statin prescribed at discharge

•

en:patients with clinical ascvd diagnosis

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:documentation of planned hybrid or staged procedure

•

en:elective delivery or early induction not performed

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:mapcp demonstration - community health teams

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:national committee for quality assurance - level 2 medical home

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:preoperative assessment documented

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:patient transferred directly from anesthetizing location to pacu

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation that patient is a current tobacco user

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:intent for potential removal at time of placement

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:i intend to report the total knee replacement measures group

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient survey score did not improve from baseline following treatment

•

en:history of receiving blood transfusions prior to 1992

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation of patient without one or more complications within 90 days

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:patients with 90 day mrs score of 0 to 2

•

en:patient alive 3 months post procedure

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:post-partum screenings, evaluations and education performed

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:documentation of patient stroke following cea

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:antiretroviral therapy prescribed

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:beta-blocker therapy not prescribed, reason not given

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:national committee for quality assurance - level 3 medical home

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:admission to medicare care choice model program (mccm)

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:door to puncture time of less than 2 hours

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:p2y inhibitor prescribed at discharge

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:currently a tobacco non-user

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:one high-risk medication ordered

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:foot exam was not performed, reason not given

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:filter removed within 3 months of placement

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:documentation of patient survival and absence of stroke following cas

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:individual had a pdc of 0.8 or greater

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:i intend to report the diabetic retinopathy measures group

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:statin not prescribed at discharge

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:documentation of viral load less than 200 copies/ml

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:antibiotic regimen prescribed

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:documentation of patient death following cas

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:documentation that the patient is not on a statin medication

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:at least two different high-risk medications ordered

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of patient with one or more complications within 90 days

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patient was not referred to hospice care, reason not given

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:patient not discharged to home by post-operative day #7

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:aspirin not prescribed at discharge

•

en:aspirin prescribed at discharge

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:biologic immune response modifier prescribed

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:history of injection drug use

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:beta-blocker therapy prescribed or currently being taken

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:preoperative assessment not documented, reason not given

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:individual did not have a pdc of 0.8 or greater

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:i intend to report the general surgery measures group

•

en:national committee for quality assurance - level 1 medical home

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patients with a normal neurological examination

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patient received follow-up within 7 days from discharge

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:current cigarette smokers

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:patients who were born in the years 1945-1965

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:patient survey results not available

•

en:patients prescribed opiates for longer than six weeks

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:patient survey score improved from baseline following treatment

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:documentation of active injection drug use

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:all necessary data elements not included, reason not given

•

en:imaging study named according to standardized nomenclature

•

en:no documentation of negative or managed positive tb screen

•

en:patients with 90 day mrs score greater than 2

•

en:post-partum screenings, evaluations and education not performed

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation that patient is a current non-tobacco user

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:prior thyroid disease diagnosis

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:monitored anesthesia care (mac)

•

en:mapcp demonstration - physician incentive pool

•

en:i intend to report the cardiovascular prevention measures group

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:antiretroviral thereapy not prescribed

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

◀

• Mathieu Lafourcade • LIRMM (données libres en Creative Commons) •

• This page link : https://www.jeuxdemots.org/diko.php?gotermid=8128449 • caches: c1=40 c2=2221 c3=2195

....

♥

po

la

ti

le

as

ku

co

lo

to

ta

ta

xe

po

li

?!

!?

[Vider le cache]